advertisement

WGA Rescources

Abstract #86641 Published in IGR 21-2

Neuroprotection in glaucoma-electrophysiology

Lešták J; Fůs M
Experimental and therapeutic medicine 2020; 19: 2401-2405


Hypertensive glaucoma is defined as a group of diseases with progressive loss of the neuroretinal margin of the optic disc that causes characteristic degenerative optic neuropathy. The present study provided an updated summary of the physiology and pathology of neurotransmission in the visual path, with the focus on glaucoma. The results of positron emission tomography, functional magnetic resonance imaging and mainly electrophysiological methods demonstrated pathogenesis of nerve cell damage in the visual pathway. Based on these conclusions, neuroprotection in glaucoma was proposed. This consists mainly of the reduction of the intraocular pressure. It is followed by a decrease of glutamate in the synaptic cleft and blockade of its binding to the NMDA receptors. The supply of energy substrates to altered nerve cells is also indispensable. Therapy should be systemic due to impairment of the complete visual path.

Full article

Classification:

11.8 Neuroprotection (Part of: 11 Medical treatment)
6.7 Electro-ophthalmodiagnosis (Part of: 6 Clinical examination methods)



Issue 21-2

Change Issue


advertisement

Oculus